中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2013年
3期
253-257
,共5页
李成强%李光俊%冀传仙%肖江洪%郭昌%全红%柏森
李成彊%李光俊%冀傳仙%肖江洪%郭昌%全紅%柏森
리성강%리광준%기전선%초강홍%곽창%전홍%백삼
ArcCHECK半导体探头%容积调强弧形治疗%剂量验证
ArcCHECK半導體探頭%容積調彊弧形治療%劑量驗證
ArcCHECK반도체탐두%용적조강호형치료%제량험증
ArcCHECK semiconductor probe%Volumetric-modulated arc therapy%Dose verification
目的 研究ArcCHECK半导体探头特性及在容积调强弧形治疗(VMAT)剂量验证应用.方法 用PTWRW3型固体水模体对ArcCHECK探头测量固有敏感性、稳定性、剂量响应、剂量率响应、每脉冲剂量响应、射野大小依赖性、角度依赖性,并与PTW31010型0.125 cm3指形电离室测量值或VMAT计划系统计算值比较.随机选取211例已验证过的VMAT计划,分析计划与测量剂量分布的γ通过率差异,两两比较采用配对t检验.结果 除角度依赖性外ArcCHECK探头其余特性均符合临床验证要求,当射束从探头底部入射时探头响应最小(180°时约为-3.9%),射束从两侧入射时响应最大(255°时约为7.7%).113例鼻咽癌、48例宫颈癌和50例直肠癌VMAT计划3 mm3%的γ平均通过率分别为93.5%、95.7%和97.5%,两两比较t=-12.69~-4.88,P均<0.01.结论 ArcCHECK半导体探头进行VMAT剂量验证前需精心校正,计划复杂度是影响VMAT计划验证通过率主要因素.
目的 研究ArcCHECK半導體探頭特性及在容積調彊弧形治療(VMAT)劑量驗證應用.方法 用PTWRW3型固體水模體對ArcCHECK探頭測量固有敏感性、穩定性、劑量響應、劑量率響應、每脈遲劑量響應、射野大小依賴性、角度依賴性,併與PTW31010型0.125 cm3指形電離室測量值或VMAT計劃繫統計算值比較.隨機選取211例已驗證過的VMAT計劃,分析計劃與測量劑量分佈的γ通過率差異,兩兩比較採用配對t檢驗.結果 除角度依賴性外ArcCHECK探頭其餘特性均符閤臨床驗證要求,噹射束從探頭底部入射時探頭響應最小(180°時約為-3.9%),射束從兩側入射時響應最大(255°時約為7.7%).113例鼻嚥癌、48例宮頸癌和50例直腸癌VMAT計劃3 mm3%的γ平均通過率分彆為93.5%、95.7%和97.5%,兩兩比較t=-12.69~-4.88,P均<0.01.結論 ArcCHECK半導體探頭進行VMAT劑量驗證前需精心校正,計劃複雜度是影響VMAT計劃驗證通過率主要因素.
목적 연구ArcCHECK반도체탐두특성급재용적조강호형치료(VMAT)제량험증응용.방법 용PTWRW3형고체수모체대ArcCHECK탐두측량고유민감성、은정성、제량향응、제량솔향응、매맥충제량향응、사야대소의뢰성、각도의뢰성,병여PTW31010형0.125 cm3지형전리실측량치혹VMAT계화계통계산치비교.수궤선취211례이험증과적VMAT계화,분석계화여측량제량분포적γ통과솔차이,량량비교채용배대t검험.결과 제각도의뢰성외ArcCHECK탐두기여특성균부합림상험증요구,당사속종탐두저부입사시탐두향응최소(180°시약위-3.9%),사속종량측입사시향응최대(255°시약위7.7%).113례비인암、48례궁경암화50례직장암VMAT계화3 mm3%적γ평균통과솔분별위93.5%、95.7%화97.5%,량량비교t=-12.69~-4.88,P균<0.01.결론 ArcCHECK반도체탐두진행VMAT제량험증전수정심교정,계화복잡도시영향VMAT계화험증통과솔주요인소.
Objective To evaluate the characteristics and clinical suitability of the ArcCHECK diode array for volumetric-modulated arc therapy (VMAT) verification.Methods The intrinsic sensitivity,short and long term reproducibility,dose and dose rate dependence,dose per pulsed dependence,field sizes dependence and directional response of the diodes were measured.The results of the diodes were compared with the measurement results of an ionization chamber and calculated results of treatment planning system.Gamma index was used to analyze the dose difference between the calculation and measurement for random selected 211 verified VMAT plans.Results The ArcCHECK performed well for all tests except directional dependence,which varies from a minimum of-3.9% (seen only when the beam was incident on the diode at 180°) to a maximum of 7.7% (approximately at 255°).Average gamma analysis passing rates with 3 mm/3% for 113 nasopharyngeal cancer,48 cervical cancer and 50 rectal cancer patients VMAT plans were 93.5%,95.7% and 97.5%,respectively,statistical significance has been found between either two of the groups (t=-12.69-4.88,all P< 0.01).Conclusions With proposed calibration method,the ArcCHECK diode array is very suitable for VMAT pretreatment verification,the complexity of VMAT plan is the main factor affecting the passing rate.